Skip to main content
Clinical Trials/NCT07619261
NCT07619261Not yet recruitingNot Applicable

Prospective Observational Study of Flow-Based Platelet Function Using T-TAS and Early Bleeding After Cardiopulmonary Bypass in Adult Cardiac Surgery

Hospital de la Santa creu i Sant Pau - Barcelona0 sites30 target enrollmentStarted: September 15, 2026Last updated:
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Not yet recruiting
Sponsor
Enrollment
30

Study Overview

Brief Summary

The goal of this observational study is to learn how flow-based platelet function measured with the Total Thrombus-formation Analysis System (T-TAS) relates to early postoperative bleeding in adults undergoing cardiac surgery with cardiopulmonary bypass. The study will also evaluate how T-TAS changes during the perioperative period and how it compares with standard coagulation and platelet function tests.

The main questions it aims to answer are:

Is lower post-cardiopulmonary bypass T-TAS Platelet-chip (PL-chip) thrombus formation associated with increased postoperative chest tube drainage during the first 12 hours after surgery? How do T-TAS parameters change before surgery, immediately after cardiopulmonary bypass, and 24 hours after surgery? Are abnormal T-TAS results associated with blood transfusion requirements, major bleeding, re-exploration for bleeding, and length of stay in the intensive care unit and hospital? Does T-TAS provide complementary information compared with standard coagulation tests, von Willebrand factor (vWF) measurements, platelet aggregometry, and viscoelastic testing?

Participants will:

Undergo blood sampling at three predefined perioperative time points:

before anesthesia induction, immediately after cardiopulmonary bypass and heparin reversal with protamine, and 24 hours after surgery Have T-TAS testing, standard laboratory coagulation tests, vWF testing, platelet aggregometry, and viscoelastic testing performed on collected samples Have clinical, surgical, transfusion, and postoperative bleeding data collected during their hospital stay

The study is observational and does not require changes to routine clinical care or perioperative management.

Detailed Description

Cardiac surgery requiring cardiopulmonary bypass (CPB) is frequently associated with perioperative hemostatic disturbances and clinically significant postoperative bleeding. The mechanisms involved are multifactorial and include platelet activation and dysfunction, hemodilution, inflammatory activation, acquired von Willebrand factor (vWF) abnormalities, fibrinolytic activation, exposure of blood to non-endothelial surfaces, hypothermia, and the effects of systemic anticoagulation and heparin reversal. These alterations contribute to increased transfusion requirements, re-exploration for bleeding, prolonged intensive care unit (ICU) stay, and increased perioperative morbidity.

Conventional coagulation tests incompletely characterize perioperative primary hemostatic dysfunction during cardiac surgery. Standard plasma-based coagulation assays provide limited information regarding platelet thrombus formation under physiologic flow conditions, while platelet aggregometry and viscoelastic testing assess only selected components of the hemostatic process. In addition, several perioperative alterations observed after CPB, particularly abnormalities involving platelet-vWF interactions under shear stress conditions, may not be adequately reflected by conventional laboratory methods.

The Total Thrombus-formation Analysis System (T-TAS) is a microfluidic flow chamber platform that evaluates thrombus formation in whole blood under controlled flow conditions. The Platelet-chip (PL-chip) primarily assesses platelet thrombus formation on collagen-coated microchannels under arterial shear flow conditions, integrating platelet adhesion, activation, aggregation, and vWF-dependent interactions. The AR-chip additionally incorporates activation of the coagulation cascade and fibrin formation. T-TAS therefore provides a functional assessment of thrombus formation under conditions that more closely resemble physiologic blood flow than conventional static coagulation assays or standard aggregometry techniques.

Although T-TAS has been investigated in several thrombotic and bleeding disorders, its perioperative behavior and potential clinical relevance in adult cardiac surgery with CPB remain insufficiently characterized. In particular, the association between post-CPB T-TAS parameters and early postoperative bleeding has not been clearly established, and the relationship between T-TAS and conventional coagulation, viscoelastic, platelet function, and vWF-related laboratory assessments remains incompletely understood in this clinical setting.

This study is a prospective, observational, single-center cohort study conducted at Hospital de la Santa Creu i Sant Pau (Barcelona, Spain). The study is designed to characterize perioperative alterations in flow-based platelet thrombus formation and to evaluate the relationship between T-TAS parameters and early postoperative bleeding after adult cardiac surgery requiring CPB.

Study Design

Study Type
Observational
Observational Model
Cohort
Time Perspective
Prospective

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Adults aged 18 years or older
  • Undergoing elective or urgent cardiac surgery requiring cardiopulmonary bypass
  • Ability to provide written informed consent

Exclusion Criteria

  • Cardiac surgery performed without cardiopulmonary bypass
  • Emergency cardiac surgery
  • Preoperative anticoagulation not reversed at the time of surgery
  • Refusal or withdrawal of informed consent
  • Known pregnancy

Arms & Interventions

Adult Cardiac Surgery With Cardiopulmonary Bypass

Adult patients undergoing elective or urgent cardiac surgery requiring cardiopulmonary bypass who undergo perioperative assessment of flow-based platelet function using the Total Thrombus-formation Analysis System (T-TAS). Participants are evaluated at predefined perioperative time points before surgery, immediately after cardiopulmonary bypass, and 24 hours postoperatively as part of a prospective observational cohort study.

Intervention: Total Thrombus-formation Analysis System (T-TAS) (Diagnostic Test)

Investigators

Sponsor
Hospital de la Santa creu i Sant Pau - Barcelona
Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Tobias Koller

Head of Cardiac Surgery ICU, MD, PhD

Hospital de la Santa creu i Sant Pau - Barcelona

Similar Trials